Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

A specific RNA helps increase the growth of skin cells in Liaoning cashmere goats by working with a protein to boost a growth-related gene.

The effectiveness of statins for women with PCOS is unclear.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The combination treatment showed a higher response rate but no significant survival benefits.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

High doses of cobalt stopped hair growth in rabbits.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.